ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir
in combination with chemoradiation for locally advanced inoperable
pancreatic cancer

ARCII: A Phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer

Background and purpose Nelfinavir can enhance intrinsic radiosensitivity, reduce hypoxia and improve vascularity. We conducted a phase II trial combining nelfinavir with chemoradiotherapy (CRT) for locally advanced inoperable pancreatic cancer (LAPC). Materials and methods Radiotherapy (50.4 Gy/28...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Wilson, J, Fokas, E, Dutton, S, Hawkins, M, al., E
التنسيق:	Journal article
منشور في:	Elsevier 2016

مواد مشابهة

ARCII: Nelfinavir, a hypoxia-modifying agent, in combination with chemoradiotherapy (CRT) in locally-advanced pancreatic cancer (LAPC)–mechanism and clinical outcomes
حسب: Wilson, J, وآخرون
منشور في: (2017)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
حسب: Brunner, T, وآخرون
منشور في: (2008)

A phase I-trial of the HIV protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer
حسب: Brunner, T, وآخرون
منشور في: (2008)

Phase I trial of the human immunodeficiency virus protease inhibitor nelfinavir and chemoradiation for locally advanced pancreatic cancer.
حسب: Brunner, T, وآخرون
منشور في: (2008)

HIV-1 genotypes related to failure of nelfinavir as the first protease inhibitor treatment
حسب: Unaí Tupinambás, وآخرون

New insights into the in silico prediction of HIV protease resistance to nelfinavir.
حسب: Dinler A Antunes, وآخرون
منشور في: (2014-01-01)

Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir
حسب: Chao Ying, وآخرون
منشور في: (2008-02-01)

Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
حسب: Holyoake, D, وآخرون
منشور في: (2016)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma.
حسب: Crosby, T, وآخرون
منشور في: (2004)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
حسب: Anjali K. Gupta, وآخرون
منشور في: (2007-04-01)

Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress-mediated, caspase-independent apoptosis in Leishmania amastigotes.
حسب: Pranav Kumar, وآخرون
منشور في: (2010-03-01)

Standard or high dose chemoradiotherapy, with or without the protease inhibitor nelfinavir, in patients with locally advanced pancreatic cancer: the phase 1/randomised phase 2 SCALOP-2 trial
حسب: Mukherjee, S, وآخرون
منشور في: (2024)

HIV protease inhibitor nelfinavir is a potent drug candidate against echinococcosis by targeting Ddi1-like protein
حسب: Zhongli Liu, وآخرون
منشور في: (2022-08-01)

Pneumocephalus after the Treatment of an Inoperable Superior Sulcus Tumor with Chemoradiation
حسب: Ashley Albert, وآخرون
منشور في: (2017-01-01)

The impact of the nelfinavir resistance-conferring mutation D30N on the susceptibility of HIV-1 subtype B to other protease inhibitors
حسب: André FA Santos, وآخرون
منشور في: (2011-03-01)

SCALOP-2: A randomised trial of induction GEMABX followed by chemoradiation (high/standard dose radiation) +/-nelfinavir for locally advanced pancreatic cancer: results of the dose-finding component
حسب: Mukherjee, S, وآخرون
منشور في: (2018)

The radiosensitizing effects of Nelfinavir on pancreatic cancer with and without pancreatic stellate cells
حسب: Al-Assar, O, وآخرون
منشور في: (2016)

Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial
حسب: Sudeep Gupta, وآخرون
منشور في: (2022-04-01)

ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
حسب: Fokas, E, وآخرون
منشور في: (2013)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
حسب: Steffi Liebscher, وآخرون
منشور في: (2017-02-01)

THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
حسب: E. P. Solov’eva, وآخرون
منشور في: (2016-02-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
حسب: Christoph Driessen, وآخرون
منشور في: (2016-03-01)

The efficacy of nelfinavir and lopinavir/ritonavir in the treatment of HIV-infected pediatric patients
حسب: V. B. Denisenko,, وآخرون
منشور في: (2018-12-01)

Chemoradiation of pancreatic carcinoma
حسب: Erdinç Nayır, وآخرون
منشور في: (2016-08-01)

Nelfinavir and Non-Nucleoside Reverse Transcriptase Inhibitor-Based Salvage Regimes in Heavily Hiv Pretreated Patients
حسب: Jean-Guy Baril, وآخرون
منشور في: (2003-01-01)

The human immunodeficiency virus-1 protease inhibitor nelfinavir impairs proteasome activity and inhibits the proliferation of multiple myeloma cells in vitro and in vivo
حسب: Camille Bono, وآخرون
منشور في: (2012-07-01)

Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation
حسب: Hilario Yankey, MD, MBA, وآخرون
منشور في: (2024-04-01)

Combination of chemoradiation therapy with immunotherapy in the treatment of patients with inoperable stage III non-small cell lung cancer
حسب: N. V. Marinichenko, وآخرون
منشور في: (2020-12-01)

Spectrophometric Determination of Nelfinavir Mesylate
حسب: K. Vanitha Prakash, وآخرون
منشور في: (2006-01-01)

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study
حسب: Alison K. Yoder, وآخرون
منشور في: (2021-07-01)

ACCELEREATED HYPERFRACTIONATED WITH UNEVEN CRUSHING DAILY DOSE WITH CHEMORADIATION TREATMENT OF INOPERABLE NON-SMALL CELL LUNG CANCER.
حسب: D. V. Gogolin, وآخرون
منشور في: (2016-02-01)

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
حسب: Léon Juan, وآخرون
منشور في: (2006-07-01)

Induction of Suicidal Erythrocyte Death by Nelfinavir
حسب: Rosi Bissinger, وآخرون
منشور في: (2015-05-01)

The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
حسب: Lenka Besse, وآخرون
منشور في: (2023-03-01)

Nelfinavir: An Old Ally in the COVID-19 Fight?
حسب: Anna Gidari, وآخرون
منشور في: (2022-12-01)

Effects of repurposed drug candidates nitroxoline and nelfinavir as single agents or in combination with erlotinib in pancreatic cancer cells
حسب: Serena Veschi, وآخرون
منشور في: (2018-09-01)

Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
حسب: Kang Young-Nam, وآخرون
منشور في: (2010-06-01)

Clinical trial of oral nelfinavir before and during radiation therapy for advanced rectal cancer
حسب: Hill, E, وآخرون
منشور في: (2016)

Downstaging of pancreatic carcinoma after neoadjuvant chemoradiation.
حسب: Tinkl, D, وآخرون
منشور في: (2009)

Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape
حسب: Camacho Ricardo J, وآخرون
منشور في: (2010-08-01)